v3.26.1
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

 

Segment Reporting for the Three Months Ended June 30, 2026

 

   Treatment   Services    Consolidated Total 
Revenue from external customers  $8,289   $4,596    $12,885 
Cost of Goods Sold:                
Payroll and benefits expenses   5,458    2,293      
Material and supplies expenses   1,573    —      
Disposal expenses   911    —      
Transportation expenses   436    —      
Subcontract expenses   —    665      
Other cost of goods sold (1)   2,563    1,489      
Total cost of goods sold   10,941    4,447      
Gross (loss) profit   (2,652)   149     
SG&A:                
Payroll and benefits   890    552      
Other SG&A (2)   396    (145)     
Total SG&A   1,286    407      
R&D   189    4      
Loss from operations  $(4,127)  $(262)    (4,389)
Interest income              203 
Interest expense              (73)
Interest expense-financing fees              (21)
Other income              136 
Unallocated corporate expenses (3)              (2,118)
Loss from continuing operations before taxes             $(6,262)

 

Segment Reporting for the Three Months Ended June 30, 2025

 

   Treatment   Services    Consolidated Total 
Revenue from external customers  $11,397   $3,189    $14,586 
Cost of Goods Sold:                
Payroll and benefits expenses   4,742    1,874      
Material and supplies expenses   1,235    —      
Disposal expenses   1,095    —      
Transportation expenses   366    —      
Subcontract expenses   —    158      
Other cost of goods sold (1)   2,393    1,176      
Total cost of goods sold   9,831    3,208      
Gross profit (loss)   1,566    (19)     
SG&A:                
Payroll and benefits   942    647      
Other SG&A (2)   408    176      
Total SG&A   1,350    823      
R&D   232    4      
Gain on disposal of property and equipment   (1)   —     
Loss from operations  $(15)  $(846)    (861)
Interest income              301 
Interest expense              (124)
Interest expense-financing fees              (21)
Other income              155 
Unallocated corporate expenses (3)              (2,033)
Loss from continuing operations before taxes             $(2,583)

 

 

Segment Reporting for the Six Months Ended June 30, 2026

 

   Treatment   Services    Consolidated Total 
Revenue from external customers  $16,168   $7,843    $24,011 
Cost of Goods Sold:                
Payroll and benefits expenses   10,222    4,421      
Material and supplies expenses   2,918    —      
Disposal expenses   2,366    —      
Transportation expenses   825    —      
Subcontract expenses   —    670      
Other cost of goods sold (1)   5,322    2,651      
Total cost of goods sold   21,653    7,742      
Gross (loss) profit   (5,485)   101     
SG&A:                
Payroll and benefits   1,768    1,162      
Other SG&A (2)   957    62      
Total SG&A   2,725    1,224      
R&D   419    4      
Loss from operations  $(8,629)  $(1,127)    (9,756)
Interest income              384 
Interest expense              (133)
Interest expense-financing fees              (43)
Other income              144 
Unallocated corporate expenses (3)              (4,233)
Loss from continuing operations before taxes             $(13,637)

 

Segment Reporting for the Six Months Ended June 30, 2025

 

   Treatment   Services    Consolidated Total 
Revenue from external customers  $20,583   $7,922    $28,505 
Cost of Goods Sold:                
Payroll and benefits expenses   9,179    3,887      
Material and supplies expenses   2,586    —      
Disposal expenses   1,316    —      
Transportation expenses   861    —      
Subcontract expenses   —    1,066      
Other cost of goods sold (1)   4,825    2,581      
Total cost of goods sold   18,767    7,534      
Gross profit   1,816    388      
SG&A:                
Payroll and benefits   1,815    1,185      
Other SG&A (2)   891    374      
Total SG&A   2,706    1,559      
R&D   523    27      
Gain on disposal of property and equipment   (1)   (5)    
Loss from operations  $(1,412)  $(1,193)    (2,605)
Interest income              636 
Interest expense              (236)
Interest expense-financing fees              (41)
Other income              188 
Unallocated corporate expenses (3)              

(4,025

)
Loss from continuing operations before taxes             $(6,083)

 

(1)  Other cost of goods sold for each reportable segment includes:
  Treatment - lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.
  Services - material and supplies, disposal, transportation, lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.
   
(2)  Other SG&A for each reportable segment includes:
  Treatment-depreciation and amortization, travel, outside services, repair and maintenance and general expenses.
  Services- travel, outside services, repair and maintenance and general expenses.
   
(3) The following table reflects the unallocated corporate expenses. “Other” unallocated corporate expenses consists of repair and maintenance, depreciation and amortization, travel, public company, outside services, general and R&D expenses. (in thousands)
Schedule of Unallocated Corporate Expenses

 

   2026   2025   2026   2025 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Payroll and benefits  $924   $940   $1,921   $1,871 
Other   1,194    1,093    2,312    2,154 
Total  $2,118   $2,033   $4,233   $4,025 
Schedule of Depreciation and Amortization

The following table presents depreciation and amortization for the three and six months ended June 30, (in thousand):

 

   2026   2025   2026   2025 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Treatment  $449   $389   $904   $771 
Services   24    38    48    81 
Total segment   473    427    952    852 
Corporate   11    10    22    21 
Total  $484   $437   $974   $873